Largest health care biotech companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 21 health care biotech companies ranked by revenue, at PLN 148.6B, ahead of Gilead Sciences (PLN 119.1B) and Biogen (PLN 40B). Figures as of 20 Nov 2026, 03:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 21
- First
- AmgenPLN 148.6B
- Median
- PLN 4.9B
- Combined market value
- PLN 3.35T
- Countries
- 5
- Not ranked
- 3no revenue on file
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | PLN 148.6B | PLN 960B | PLN 1,774.74 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | PLN 119.1B | PLN 835.4B | PLN 673.51 | 1.45% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | PLN 40B | PLN 147.7B | PLN 999.48 | 1.70% down | 49% up | ||
| 4 | argenxARGX · Health Care | PLN 16.8B | PLN 239.6B | PLN 3,809.94 | 0.08% up | 2% up | ||
| 5 | BioNTechBNTX · Health Care | PLN 12.9B | PLN 81.6B | PLN 329.13 | 2.26% down | 14% down | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | PLN 11.6B | PLN 64.1B | PLN 633.30 | 3.85% down | 17% up | ||
| 7 | ExelixisEXEL · Health Care | PLN 9.4B | PLN 65B | PLN 266.24 | 3.60% down | 63% up | ||
| 8 | QiagenQGEN · Health Care | PLN 8.5B | PLN 41.4B | PLN 200.72 | 0.14% up | 9% up | ||
| 9 | ModernaMRNA · Health Care | PLN 7.9B | PLN 326.2B | PLN 806.16 | 1.29% up | 780% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | PLN 5.6B | PLN 42.9B | PLN 376.29 | 2.88% down | 39% up | ||
| 11 | Bio-TechneTECH · Health Care | PLN 4.9B | PLN 46.2B | PLN 294.02 | 0.07% down | 24% up | ||
| 12 | RepligenRGEN · Health Care | PLN 3B | PLN 44B | PLN 688.71 | 1.38% down | 12% up | ||
| 13 | Krystal BiotechKRYS · Health Care | PLN 1.6B | PLN 37.9B | PLN 1,277.29 | 0.15% up | 54% up | ||
| 14 | Twist BioscienceTWST · Health Care | PLN 1.5B | PLN 30.8B | PLN 451.43 | 4.07% down | 346% up | ||
| 15 | Adaptive BiotechnologiesADPT · Health Care | PLN 1.1B | PLN 18.4B | PLN 113.44 | 1.44% down | 74% up | ||
| 16 | ImmunityBioIBRX · Health Care | PLN 458.2M | PLN 28.3B | PLN 26.57 | 1.94% down | 232% up | ||
| 17 | Kymera TherapeuticsKYMR · Health Care | PLN 158.6M | PLN 41.2B | PLN 482.85 | 1.44% down | 87% up | ||
| 18 | CG OncologyCGON · Health Care | PLN 16.3M | PLN 29.6B | PLN 331.23 | 2.38% up | 97% up | ||
| 19 | CRISPR TherapeuticsCRSP · Health Care | PLN 14.2M | PLN 15.3B | PLN 157.45 | 3.14% down | 18% down | ||
| 20 | Revolution MedicinesRVMD · Health Care | PLN 0 | PLN 139.5B | PLN 644.79 | 0.24% down | 129% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | PLN 0 | PLN 24.9B | PLN 203.71 | 4.94% up | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0443 PLN). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care biotech companies rank first by revenue?
Amgen (PLN 148.6B), Gilead Sciences (PLN 119.1B) and Biogen (PLN 40B) are the top three of the 21 health care biotech companies ranked by revenue as of 20 Nov 2026, 03:27 UTC.
How many health care biotech companies are in this ranking?
21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these health care biotech companies worth together?
The 21 health care biotech companies ranked by revenue have a combined market value of PLN 3.35T as of 20 Nov 2026, 03:27 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care biotech companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.